Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
We have a wide range of fun and festive designs to choose from. Fund life changing research while spreading joy this Christmas!
This Christmas, your gift can bring us closer to a cure for type 1 diabetes – and every pound you give to our Christmas Appeal will be doubled.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
This event is designed for anyone living with type 1 diabetes who would like to learn more about managing their wellbeing across a variety of contexts.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > Dexcom launches G7 continuous glucose monitor
The G7 is the latest version of Dexcom’s range of continuous glucose monitors (CGM).
The G7 is 60% smaller than the previous model, the G6. It also warms up more quickly, so you can start to use it after 30 minutes.
It also has an integrated sensor and transmitter, which makes it easier to apply, and unlike the G6, the G7 is fully disposable. The G7 has improved accuracy and can be worn in more places; on the upper arm, abdomen, or – for children aged between 2 and 6 – on their upper buttocks.
The G7 has improved alert settings and has a redesigned receiver that is smaller but with a display that is easier to read. The mobile app has also been redesigned and simplified. Plus, there is a 12 hour ‘grace period’ giving greater flexibility on when you need to replace the CGM.
Many CGMs are compatible with insulin pumps to create a hybrid closed loop system which automates insulin delivery.
The G7 is currently not compatible with insulin pumps, so it can’t be used as part of a hybrid closed-loop system (also known as the artificial pancreas). However, there are plans to develop this capability in the future.
CGMs are used to monitor glucose levels in real-time, throughout the day and night, and relieve the burden of having to do multiple finger prick tests throughout the day.
Although the G7 can’t form part of a closed loop system, it may be beneficial for children and adults who use multiple daily injections of insulin and want to use a CGM to monitor their glucose levels. It’s also recommended for people who find it difficult to recognise the signs and symptoms of a hypo, known as hypo unawareness.
If your healthcare professional feels that you would get a specific benefit from using the G7 rather than other CGMs, they will be able to order one for you.
A landmark international agreement on the treatment and support for people living with type 1 diabetes using Do-it-Yourself (DIY) artificial pancreas technology has been published today.
JDRF is delighted that the National Institute for Healthcare and Care Excellence (NICE) has published draft guidelines recommending that all adults with type 1 diabetes should be offered a choice of flash or continuous glucose monitoring (CGM) in England.
JDRF is delighted to have contributed to a new report, published in January 2022, which has issued recommendations for NHS Scotland, aimed at widening access to closed-loop systems for all people with type 1 diabetes in Scotland.
New guidance for the NHS in England published today has recommended that people with type 1 diabetes be offered a choice of flash monitoring or continuous glucose monitoring (CGM) on the NHS.
Don’t miss out on the latest research, inspiring stories, tech news, upcoming events, and handy information on living well with type 1. Join us now and receive it all straight to your inbox.
It’s thanks to your dedication that we have funded great progress in type 1 cure, treatment and prevention research. Help us to continue our vital research.